Federal Trade Commission v. AbbVie Inc

Opinion

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

Nos. 18-2621, 18-2748 & 18-2758

FEDERAL TRADE COMMISSION, Appellant in 18-2621

v.

ABBVIE INC; ABBOT LABORATORIES; UNIMED PHARMACEUTICALS, LLC; BESINS HEALTHCARE, INC; *TEVA PHARMACEUTICALS USA INC

AbbVie Inc; Abbott Laboratories; Unimed Pharmaceuticals, LLC, Appellants in No. 18-2748

Besins Healthcare, Inc., Appellant in No. 18-2758

(Dismissed Pursuant to Court’s 3/12/19 Order.)

(E.D. Pa. No. 2-14-cv-05151)

Present: HARDIMAN, PORTER and PHIPPS, Circuit Judges

_________________________________ORDER________________________________ On further review of the opinion filed in the above captioned cases, the Court has determined that a word should be added on page 96. The opinion is hereby amended so that the last sentence of the first paragraph on p. 96 reads, “To the extent the FTC did not timely raise this argument in the District Court, it is forfeited on appeal.”

The Clerk is directed to file the amended opinion simultaneously with this order.

By the Court,

s/ Thomas M. Hardiman Circuit Judge Dated: December 4, 2020 CJG/cc: All Counsel of Record